Largest biotech companies in the United States by total assets

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 20 biotech companies in the United States ranked by total assets, at $90.6B, ahead of Gilead Sciences ($59B) and Biogen ($29.4B). Figures as of 19 Nov 2026, 15:09 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Amgen$90.6B
Median
$2.4B
Combined market value
$739.8B
Countries
1

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Largest biotech companies in the United States by total assets
#CompanyTotal assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$90.6B$238.9B$441.64 0.51% down 32% up United States
2Gilead SciencesGILD · Health Care$59B$207.3B$167.17 1.07% down 35% up United States
3BiogenBIIB · Health Care$29.4B$36.7B$248.20 1.28% down 49% up United States
4ModernaMRNA · Health Care$12.3B$79B$195.35 0.73% down 780% up United States
5Neurocrine BiosciencesNBIX · Health Care$4.6B$16.3B$160.76 1.29% down 17% up United States
6VaxcytePCVX · Health Care$3B$9.5B$60.01 2.55% up 23% up United States
7RepligenRGEN · Health Care$2.9B$11.3B$176.25 2.07% up 12% up United States
8ExelixisEXEL · Health Care$2.8B$16.2B$66.47 2.67% down 63% up United States
9Bio-TechneTECH · Health Care$2.6B$11.4B$72.70 0.07% down 24% up United States
10Halozyme TherapeuticsHALO · Health Care$2.5B$10.6B$92.80 3.14% down 39% up United States
11Revolution MedicinesRVMD · Health Care$2.4B$35.9B$166.04 3.89% up 129% up United States
12Kymera TherapeuticsKYMR · Health Care$1.7B$10.3B$121.19 0.05% up 87% up United States
13Krystal BiotechKRYS · Health Care$1.3B$9.4B$317.87 0.80% up 54% up United States
14ImmunovantIMVT · Health Care$957M$6.9B$33.52 1.06% up 46% up United States
15CG OncologyCGON · Health Care$791.6M$7.2B$81.11 1.39% up 97% up United States
16Twist BioscienceTWST · Health Care$641.9M$8.4B$122.97 5.69% up 346% up United States
17Adaptive BiotechnologiesADPT · Health Care$512.7M$4.7B$29.13 2.35% up 74% up United States
18ImmunityBioIBRX · Health Care$501.9M$7.1B$6.71 0.15% up 232% up United States
19Scholar Rock HoldingSRRK · Health Care$404.3M$6.1B$49.61 3.35% up 26% up United States
20Kodiak SciencesKOD · Health Care$351.5M$6.5B$99.02 1.24% up 399% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which biotech companies in the United States rank first by total assets?

Amgen ($90.6B), Gilead Sciences ($59B) and Biogen ($29.4B) are the top three of the 20 biotech companies in the United States ranked by total assets as of 19 Nov 2026, 15:09 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by total assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by total assets have a combined market value of $739.8B as of 19 Nov 2026, 15:09 UTC.

What does ranking by total assets measure?

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech companies in the United States by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-assets

Underlying data: Yahoo Finance; SEC EDGAR.